Al Tamimi DM, Shawarby MA, Ahmed A, Hassan AK, Alodaini AA (2010) Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study. BMC Cancer 10:223. https://doi.org/10.1186/1471-2407-10-223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Foheidi M, Al-Mansour MM, Ibrahim EM (2013) Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries. Med Oncol 30(2):471. https://doi.org/10.1007/s12032-013-0471-5

Article  PubMed  Google Scholar 

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297. https://doi.org/10.1016/S0092-8674(04)00045-5

Article  CAS  PubMed  Google Scholar 

Blenkiron C and Miska EA. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 2007; 16 Spec No 1: R106 - R113. https://doi.org/10.1093/hmg/ddm056

Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999–3004. https://doi.org/10.1073/pnas.0307323101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, Zhang J, Zhang C-Y (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28(10):1385–1392. https://doi.org/10.1038/onc.2008.474

Article  CAS  PubMed  Google Scholar 

Di Leva G, Croce CM (2013) miRNA profiling of cancer. Curr Opin Genet Dev 23(1):3–11. https://doi.org/10.1016/j.gde.2013.01.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang Y, Sun B, Li Z, Chen Z (2020) Recent advances in nanomedicine for breast cancer therapy. Cancer Treat Rev 86:102016

Google Scholar 

Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, Kreike B, Sie D, Hovestadt V, Wessels LF, van de Vijver MJ, Tuschi T (2011) MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71(13):4443–4453. https://doi.org/10.1158/0008-5472.CAN-11-0608

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378(9801):1461–1484. https://doi.org/10.1016/S0140-6736(11)61351-2

Article  PubMed  Google Scholar 

Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH (2007) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026–1033. https://doi.org/10.1074/jbc.M707224200

Article  CAS  PubMed  Google Scholar 

Gao YC, Wu J, MicroRNA X (2019) MicroRNA-155 regulates the proliferation, cell cycle, apoptosis, and migration of colon cancer cells and targets CBL. Exp Ther Med 18(2):1225–1232

Google Scholar 

Guo L, Zhao Y, Yang S, Cai M, Wu Q, Chen F (2013) Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer. Mol Biol Rep 40(3):2175–2186. https://doi.org/10.1007/s11033-012-2277-5

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

Article  CAS  PubMed  Google Scholar 

Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12(9):613–626

Article  CAS  PubMed  Google Scholar 

Huh JH, Kim TH, Kim K, Song J-A, Jung YJ, Jeong J-Y, Lee MJ, Kim YK, Lee DH, An HJ (2013) Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Br J Cancer 109(2):452–461. https://doi.org/10.1038/bjc.2013.305

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065–7070. https://doi.org/10.1158/0008-5472.CAN-05-1783

Article  CAS  PubMed  Google Scholar 

Iorio MV, Casalini P, Tagliabue E, Menard S, Croce CM (2008) MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 44(18):2753–2759. https://doi.org/10.1016/j.ejca.2008.09.037

Article  CAS  PubMed  Google Scholar 

Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ (2005) RAS in regulated by the let-7 microRNA family. Cell 120(5):635–647. https://doi.org/10.1016/j.cell.2005.01.014

Article  CAS  PubMed  Google Scholar 

Khan AQ, Ahmed EI, Elareer NR, Junejo K, Steinhoff M, Uddin S (2021) Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies. Cells 10(7):1632

Google Scholar 

Lagendijk M, Sadaatmand S, Koppert LB, Tilanus-Linthorst MMA, de Weerd V, Ramirez-Moreno R, Smid M, Sieuwerts AM, Martens JWM (2018) MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer. Oncotarget 9(36):24335–24346. https://doi.org/10.18632/oncotarget.25262

Article  PubMed  PubMed Central  Google Scholar 

Li J, Wang Y, Song Y, Fu Z, Yu W, Zhou M (2020) miR-21, miR-200 family, and miR-205 are promising diagnostic and prognostic miRNAs for breast cancer. BMC Cancer 20(1):1–12

Google Scholar 

Liang Y, Zhang H, Song X. and Yang, Q. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. In Seminars in cancer biology . 2020 60: 14–27). Academic Press.

Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449(7163):682–688. https://doi.org/10.1038/nature06174

Article  CAS  PubMed  Google Scholar 

Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG (2009) DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 25(15):1991–1993. https://doi.org/10.1093/bioinformatics/btp299

Article  CAS  PubMed  Google Scholar 

Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C, Dalamagas T, Hatzigeorgiou AG (2013) DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 41(W1):W169–W173. https://doi.org/10.1093/nar/gkt393

Article  PubMed  PubMed Central  Google Scholar 

Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffery SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumors. Nature 406(6797):747–752. https://doi.org/10.1038/35021093

Article  CAS  PubMed  Google Scholar 

Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67(24):11612–11620. https://doi.org/10.1158/0008-5472.CAN-07-5019

Article  CAS  PubMed  Google Scholar 

Si M-L, Zhu S, Wu H, Lu Z, Wu F, Mo Y-Y (2007) miR-21-mediated tumor growth. Oncogene 26:2799–2803. https://doi.org/10.1038/sj.onc.1210083

Article  CAS  PubMed  Google Scholar 

Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffery SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. https://doi.org/10.1073/pnas.191367098

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588–590. https://doi.org/10.1097/01.ede.0000229195.98786.ee

Article  PubMed  Google Scholar 

van Schooneveld E, Wouters MC, van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ (2012) Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res 14(1):R34. https://doi.org/10.1186/bcr3127

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM (2012a) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci USA 109(8):3024–3029. https://doi.org/10.1073/pnas.1200010109

Article  PubMed  PubMed Central  Google Scholar 

Volinia S, Croce CM, Prognostic S (2012b) Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci 109(8):2824–2829

Google Scholar 

Wu D, Zhang J, Fan Z (2021) Targeting miRNAs in breast cancer: Recent advances and future challenges. Mol Cancer 20(1):1–17

Google Scholar 

Yan L, Li X, X L, & Pan Z (2021) MicroRNA expression patterns in the development, progression, diagnosis, and prognosis of breast cancer. Medicine 100(35):e27151

Google Scholar 

Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W, Liu J, Yu J, Chen J (2010) miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 70(14):6015–6025. https://doi.org/10.1158/0008-5472.CAN-09-4531